Our Director, Paul Cronin, is excited to be back on the road in September and to be attending RESI in Boston! - For support when developing your therapeutic or medicinal product, search 'Scendea' in the partnering platform or get in touch www.scendea.com/contact - #partnering #drugdevelopment #RESI #regulatoryaffairs
Scendea’s Post
More Relevant Posts
-
Any #ClinicalTrial team bringing an investigational medicinal product to market needs to first understand the potential risks and opportunities around its program. Advarra covers the key elements of a successful clinical development plan in this white paper. https://bit.ly/3VCIfsl
-
-
Combined Advanced Therapy Medicinal Products (CATMPs) hold immense promise for patients, but navigating their development can be complex due to unique regulatory requirements. Our latest blog dives into the challenges and opportunities surrounding CATMPs in Europe. We explore the current regulatory landscape and how it's evolving to support this innovative field. https://lnkd.in/gZ8umkSz #FortreaAlwaysOn
-
-
Combined Advanced Therapy Medicinal Products (CATMPs) hold immense promise for patients, but navigating their development can be complex due to unique regulatory requirements. Our latest blog dives into the challenges and opportunities surrounding CATMPs in Europe. We explore the current regulatory landscape and how it's evolving to support this innovative field. #FortreaAlwaysOn https://lnkd.in/dtmtUpsj
-
-
Combined Advanced Therapy Medicinal Products (CATMPs) hold immense promise for patients, but navigating their development can be complex due to unique regulatory requirements. Our latest blog dives into the challenges and opportunities surrounding CATMPs in Europe. We explore the current regulatory landscape and how it's evolving to support this innovative field. https://lnkd.in/dvN8-ezp
-
-
Combined Advanced Therapy Medicinal Products (CATMPs) hold immense promise for patients, but navigating their development can be complex due to unique regulatory requirements. Our latest blog dives into the challenges and opportunities surrounding CATMPs in Europe. We explore the current regulatory landscape and how it's evolving to support this innovative field. https://lnkd.in/gP5UEyCs
-
-
Strategic Transformation | 19 Patents | PSPO™ | PSM™ | LSSWB | LSSYB | LPLG | Microsoft Power BI Certified | Program And Project Management | Vendor Management | Operational Excellence| Data Analytics
Combined Advanced Therapy Medicinal Products (CATMPs) hold immense promise for patients, but navigating their development can be complex due to unique regulatory requirements. Our latest blog dives into the challenges and opportunities surrounding CATMPs in Europe. We explore the current regulatory landscape and how it's evolving to support this innovative field. https://lnkd.in/dp9ybFGm
-
-
Combined Advanced Therapy Medicinal Products (CATMPs) hold immense promise for patients, but navigating their development can be complex due to unique regulatory requirements. Our latest blog dives into the challenges and opportunities surrounding CATMPs in Europe. We explore the current regulatory landscape and how it's evolving to support this innovative field. https://lnkd.in/eXHxVFUx
-
-
Combined Advanced Therapy Medicinal Products (CATMPs) hold immense promise for patients, but navigating their development can be complex due to unique regulatory requirements. Our latest blog dives into the challenges and opportunities surrounding CATMPs in Europe. We explore the current regulatory landscape and how it's evolving to support this innovative field. https://lnkd.in/eDBSmAC4
-
-
Combined Advanced Therapy Medicinal Products (CATMPs) hold immense promise for patients, but navigating their development can be complex due to unique regulatory requirements. Our latest blog dives into the challenges and opportunities surrounding CATMPs in Europe. We explore the current regulatory landscape and how it's evolving to support this innovative field. https://lnkd.in/eMcA9zSb
-
-
Combined Advanced Therapy Medicinal Products (CATMPs) hold immense promise for patients, but navigating their development can be complex due to unique regulatory requirements. Our latest blog dives into the challenges and opportunities surrounding CATMPs in Europe. We explore the current regulatory landscape and how it's evolving to support this innovative field. https://lnkd.in/eMVP86FR
-
